Navigation Links
Otonomy Acquires Assets and Patent Rights for Tinnitus Program
Date:10/31/2013

lifies our commitment to broadly address unmet medical need in the treatment of otic disorders."

"We are pleased to transfer the data and results from our efforts, and IP surrounding gacyclidine to further the development of OTO-311. We believe that prolonged drug exposure to the inner ear is essential for optimal treatment and that Otonomy's technology featuring single injection delivery is a patient friendly innovation," stated Alfred Mann. "OTO-311 has exciting potential to provide relief to the millions of individuals worldwide who suffer from tinnitus."

About Tinnitus

Tinnitus is the medical term for hearing noises in the ears when there is no outside source of the sounds. It is often described as a ringing in the ears but can also sound like roaring, clicking, hissing or buzzing, and can be soft or loud. An estimated one in five adults may experience tinnitus in one or both ears. While the most common cause of tinnitus is exposure to loud noise, a number of other factors can be involved including heart or blood vessel problems, hormonal changes in women, ear and sinus infections, certain medications and thyroid problems. People with severe tinnitus may have trouble hearing, working or even sleeping. At this time, there is no cure for tinnitus and there are no FDA-approved drugs for treating this debilitating condition.

About Otonomy

Otonomy is a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the ear. Otonomy's proprietary technology provides sustained exposure of drugs to the middle and inner ear following a single intratympanic (IT) injection. Otonomy has three product candidates in development. OTO-104 is a steroid that has completed a Phase 1b clinical trial in Meniere's disease patients. OTO-201 is an antibiotic that has recently completed a Phase 1b clinical trial in pediatric patients with middle ear effusion at the time of tympanost
'/>"/>

SOURCE Otonomy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Otonomy Completes $45.9 Million Series C Equity Financing
2. WebMD Acquires Avado, Inc.
3. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
4. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
5. Johns Hopkins Kimmel Cancer Center Acquires Elekta Versa HD System
6. MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
7. Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
8. WIKA Process Solutions, Deer Park, Texas Acquires Gayesco International.
9. ITC Acquires Accumetrics to Form Leading POC Cardiovascular Diagnostics Business
10. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
11. IDEXX Laboratories Acquires Brazil Distributor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Cardica, Inc. (Nasdaq: CRDC ) today announced ... quarter and year ended June 30, 2014, on Thursday, August ... a conference call at 4:30 p.m. Eastern Time to discuss ... business. Conference Call Details To access the live ... Time via phone, please dial 866-953-6859 from the ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... ENGLEWOOD, Colo. , July 23 2014 ... opening of its new headquarters, manufacturing and research facility: ... Englewood, CO 80112 Direct: (720) 437-6500 ... advanced, labor efficient, pharmaceutical drug manufacturing facility will be ... to produce the first batches of Ampion TM ...
Breaking Medicine Technology:Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... Pa., Feb. 16, 2011 AirPal, a medical device ... of allowance from the U.S. Patent Office for its ... for situations such as difficult airway management, laryngoscopies, diagnostic ... founded in 1982, now holds more than a dozen ...
... YORK, Feb. 16, 2011 Get content from ... The European Parliament is expected ... prevent falsified medicines from entering the legal distribution ... packages have reached patients in the last years. ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2
(Date:7/23/2014)... of research suggesting a safe and effective role ... cancer, with fewer detrimental side effects and improved ... study will be published in final format today ... Endocrinology . , Breast cancer is the most ... States. Approximately 70% of breast cancers are diagnosed ...
(Date:7/23/2014)... of Biomedical Imaging and Bioengineering will host its second ... 2014 on the NIH campus. There will be ten ... breadth of NIBIB-funded research. , WHO: ... Rhodopsins as Optical Voltage Sensor, Quyen Nguyen, Univ. ... Nerve Imaging during Surgery, ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... New York (PRWEB) July 23, 2014 ... continue to move forward in a federal multidistrict litigation ... Bernstein Liebhard LLP reports. According to an Order dated ... a hospital’s bid for payment of a $1,000 fee ... hip implant. , Among other things, the Order ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a ... other behaviors on the autistic spectrum, as well as ... of mental impairment and the most common cause of ... California, Riverside have published a study that ... FXS. Appearing online today (July 23) in the ...
Breaking Medicine News(10 mins):Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3
... 6, 2009) The American Association of Pharmaceutical Scientists ... Ph.D., to the position of Research Fellow at the ... she will begin work this week to develop effective ... appointment comes at the end of a collaborative effort ...
... 12th annual Boston Stroke Luncheon "Making the Stroke Connection" will ... Boston from 7:30 a.m. to 12 p.m. Activities include a ... End Stroke Ambassador Training, and an awards celebration lunch from ... Janet Wu. , Milton Resident Margaret Kelly-Hayes, EdD, ...
... big chunk of change" to make Jen Ross smile. This ... raise more than $1,000 for Custom Hearts , ... heart defects or heart disease."Now that we have a big chunk ... things that we,ve wanted to do for a year and a ...
... Misperceptions About Donation Are CommonRICHMOND, Va., April 14 ... organ and tissue donors is rising, the registry still ... a report card issued by Donate Life America this ... Americans, 72 percent of people want their decision to ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) ... to the market opening on April 30, 2009. Truman ... call with the investment community later that same day beginning ... expect to hear management discuss past results as well as ...
... Association Becomes Only Major Parkinson,s Organization to Launch ... Parkinson,s DiseaseSTATEN ISLAND, N.Y., April 14 The ... Center has launched a re-designed Web site, ... onset Parkinson,s disease (PD), their family members, friends, ...
Cached Medicine News:Health News:AAPS and FDA announce appointment of research fellow 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:TAN's Efforts Produce 'Chunk of Change' for Children With Heart Defects 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 3Health News:New Young Onset Parkinson's Disease Web Site Goes Live 2Health News:New Young Onset Parkinson's Disease Web Site Goes Live 3
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
The Convertible lets you attach the,High Lite optic directly to your loupes....
... is a product of AlloSource, one ... human tissue processing, and Interpore Cross, ... InterGro combines AlloGro DBM with ... deliver a unique bone graft that ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
Medicine Products: